123 related articles for article (PubMed ID: 36689318)
1. Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.
Povýšil C; Hojný J; Kaňa M
Folia Biol (Praha); 2022; 68(3):112-124. PubMed ID: 36689318
[TBL] [Abstract][Full Text] [Related]
2. Target-like chondrocytes with thick perichondrocytic rings in cartilage-forming tumours. Preliminary report.
Povysil C; Kana M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Jun; 165(2):203-208. PubMed ID: 33928945
[TBL] [Abstract][Full Text] [Related]
3. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical and ultrastructural study of the pericellular matrix of uneroded hypertrophic chondrocytes in the mandibular condyle of aged c-src-deficient mice.
Shibata S; Baba O; Oda T; Yokohama-Tamaki T; Qin C; Butler WT; Sakakura Y; Takano Y
Arch Oral Biol; 2008 Mar; 53(3):220-30. PubMed ID: 18068147
[TBL] [Abstract][Full Text] [Related]
6. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
Daugaard S; Christensen LH; Høgdall E
APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
9. Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones.
Noonan KJ; Hunziker EB; Nessler J; Buckwalter JA
J Orthop Res; 1998 Jul; 16(4):500-8. PubMed ID: 9747793
[TBL] [Abstract][Full Text] [Related]
10. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
[TBL] [Abstract][Full Text] [Related]
11. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.
Goh YW; Spagnolo DV; Platten M; Caterina P; Fisher C; Oliveira AM; Nascimento AG
Histopathology; 2001 Nov; 39(5):514-24. PubMed ID: 11737310
[TBL] [Abstract][Full Text] [Related]
12. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
Huse JT; Pasha TL; Zhang PJ
Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
[TBL] [Abstract][Full Text] [Related]
13. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
Aigner T
Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
[TBL] [Abstract][Full Text] [Related]
14. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical studies on the tissue localization of collagen types I, III, IV, V and VI in schwannomas. Correlation with ultrastructural features of the extracellular matrix.
Oda Y; Kawahara E; Minamoto T; Ueda Y; Ikeda K; Nagai Y; Nakanishi I
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):153-63. PubMed ID: 2906188
[TBL] [Abstract][Full Text] [Related]
16. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.
Aigner T; Dertinger S; Vornehm SI; Dudhia J; von der Mark K; Kirchner T
Am J Pathol; 1997 Jun; 150(6):2133-41. PubMed ID: 9176404
[TBL] [Abstract][Full Text] [Related]
18. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
19. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
